Shirelle Janine Naidoo

Ms. Shirelle Janine Naidoo


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 December 2015 in Journal of Religion and Health
Verified
Journal Article
Closed access
PDF file
TKTasnim Bibi Kazi
Tasnim Bibi Kazi
SNShirelle Janine Naidoo
Shirelle Janine Naidoo

19 September 2017 in Psychology and Developing Societies
Verified
Journal Article
Closed access
SNShirelle Janine Naidoo
Shirelle Janine Naidoo
SCSteven J. Collings
Steven J. Collings
In Africa, data on the prevalence and predictors of death and suicidal ideation is lacking. In this study, a cross-sectional design was used to investigate the prevalence and risk factors for death and suicidal ideation in a cohort of 239 psychiatric patients receiving outpatient treatment at nine sites in the Durban area (South Africa) in 2015. Prevalence rates for death and suicidal ideation were high, with 35 (16%) patients reporting death ideation and 95 (40%) reporting suicidal ideation. Both death and suicidal ideation were significantly associated with unemployment (ORs = 2.61 and 2.34, respectively) and a primary diagnosis of depressive disorder (ORs = 4.72 and 6.54, respectively). Factors that uniquely predicted death ideation were: not being in an intimate relationship (OR = 6.45), ethnicity (being Indian South African: OR = 3.28) and a primary diagnosis of bipolar disorder (OR = 4.61), with suicidal ideation being uniquely predicted by a lower level of educational attainment (OR 2.86), ethnicity (being Black South African: OR = 3.36) and a primary diagnosis of borderline personality disorder (OR = 7.14). Study findings are discussed in terms of their implications for practice and future research.

Verified
Journal Article
Open access
PDF file
SNShirelle Janine Naidoo
Shirelle Janine Naidoo
TNThajasvarie naickera@ukzn.ac.za
Thajasvarie naickera@ukzn.ac.za
Cytokines coordinate the intricate choreography of the immune system, directing cellular activities that mediate inflammation, pathogen defense, pathology and tissue repair. Within this spectrum, the anti-inflammatory prowess of interleukin-10 (IL-10) predominates in immune homeostasis. In normal pregnancy, the dynamic shift of IL-10 across trimesters maintains maternal immune tolerance ensuring fetal development and pregnancy success. Unravelling the dysregulation of IL-10 in pregnancy complications is vital, particularly in the heightened inflammatory condition of preeclampsia. Of note, a reduction in IL-10 levels contributes to endothelial dysfunction. In human immunodeficiency virus (HIV) infection, a complex interplay of IL-10 occurs, displaying a paradoxical paradigm of being immune-protective yet aiding viral persistence. Genetic variations in the IL-10 gene further modulate susceptibility to HIV infection and preeclampsia, albeit with nuanced effects across populations. This review outlines the conceptual framework underlying the role of IL-10 in the duality of normal pregnancy and preeclampsia together with HIV infection, thus highlighting its regulatory mechanisms and genetic influences. Synthesizing these findings in immune modulation presents avenues for therapeutic interventions in pregnancy complications comorbid with HIV infection.

2 December 2017 in Social Behavior and Personality: an international journal
Verified
Journal Article
Closed access
SNShirelle Janine Naidoo
Shirelle Janine Naidoo
SCSteven J. Collings
Steven J. Collings
Proponents of the interpersonal-psychological theory of suicide have theorized that an acquired capability for suicide is a key construct in the development of high-risk suicidal behavior. However, extant measures do not adequately capture the content domains of this construct. Using 239 psychiatric outpatients recruited from public and private psychiatry and psychology sites, we validated a measure of acquired capability derived from extant measures, the Death Inurement Scale (DIS) in the South African context. The results suggest that the DIS explains additional variance in suicide risk above the measures previously used and provide support for its incremental validity.

4 October 2025 in LabMed
Verified
Journal Article
Open access
PDF file
NMNqobile Mthembu
Nqobile Mthembu
SPSureshnee Pillay
Sureshnee Pillay
HMHastings Twalie Musopole
Hastings Twalie Musopole
SNShirelle Janine Naidoo
Shirelle Janine Naidoo
NMNokukhanya B Msomi
Nokukhanya B Msomi
JGJennifer Giandhari
Jennifer Giandhari
Acute respiratory infections (ARIs) continue to pose a major global health threat, particularly among vulnerable populations. These infections often present with similar clinical symptoms, complicating accurate diagnosis and facilitating unmonitored transmissions. Genomic surveillance has emerged as an invaluable tool for pathogen identification and monitoring of such infectious pathogens; however, its implementation is frequently limited by high costs. The widespread use of high-throughput sequencing during the COVID-19 pandemic has created an opportunity to repurpose existing genomic platforms for broader respiratory virus surveillance. In this study, we evaluated the feasibility of adapting the Illumina COVIDSeq assay—initially designed for SARS-CoV-2 whole-genome sequencing—for use with Influenza A/B, Respiratory Syncytial Virus (RSV), and Rhinovirus. Positive control samples were processed using two approaches for library preparation: four virus-specific multiple workflows and a combined rapid workflow. Both workflows incorporated pathogen-specific primers for amplification and followed the Illumina COVIDSeq protocol for library preparation and sequencing. Sequencing quality metrics were analysed, including Phred scores, read length distribution, and coverage depth. The study did not identify significant differences in genome coverage and genetic diversity metrics between workflows. Genome Detective consistently identified the correct species across both methods. The findings of this study demonstrate that the COVIDSeq assay can be effectively adapted for multi-pathogen genomic surveillance and that the combined rapid workflow can offer a cost- and labour-efficient alternative with minimal compromise to data quality.